期刊文献+

^(117)Sn^m标记HEDTMP的研究 被引量:4

PREPARATION AND CHARACTERISTICS OF ^(117)Sn^m-HEDTMP
下载PDF
导出
摘要 合成了亲骨性的氨基膦类化合物HEDTMP(羟乙基乙二胺三甲撑膦酸 ) ,研究了117Snm(Ⅳ )标记HEDTMP的条件、标记物的稳定性、亲脂性及在小鼠体内的分布。结果表明 ,117Snm(Ⅳ )与HEDTMP在常温下反应 5min即可形成标记率大于 95 %的配合物 ;酸度和配体量对溶液外观有较大的影响 ,但不影响标记率 ;117Snm(Ⅳ ) HEDTMP的稳定性较好 ,属亲水性配合物。小鼠体内分布实验表明 ,配合物主要为骨骼摄取 。 HEDTMP[N-(2-hydroxyethyl)ethylenediamine-1,1,2-tri(methylenephosphonic acid] is synthesized and labeled with 117Sn m(Ⅳ).The labeling conditions,stability,lipophiljcity and biodistribution of 117Sn m-HEDTMP in mice are investigated. The results show that the labeling yield of HEDTMP with 117Sn m(Ⅳ) is higher than 95% in 5 min after reaction at room temperature. Acidity and ligand dosage exert great influence to exterior of reaction solution, but labeling yield is still high. The 117Sn m-HEDTMP is very stable at room temperature and 37 ℃ and is hydrophilic. The biodistribution experiments of 117Sn m-HEDTMP in mice show that uptake of the membra bone is higher at 4 h after injection, the uptake of other tissues is low.
出处 《核化学与放射化学》 CAS CSCD 北大核心 2002年第4期236-239,共4页 Journal of Nuclear and Radiochemistry
基金 中国工程物理研究院军民两用技术开发资助项目 (JM 2 0 0 0 8)
  • 相关文献

参考文献4

  • 1QAIM S M,DOHLER H.Production of Carrier-Free 117Snm [J]. Int J Appl Radiat Isot,1984,35(7):645.
  • 2HAIOLD L A,LEONARD F M,SURESH C S,et al.Biodistribution of Sn-117m(4+) DTPA for Palliative Therapy of Painful Osseous Metastases[J]. Radiology,1993,186:279~283.
  • 3KRISHNAMURTHY G T,SWAILEM F M,WALSH T K. Pharmaco-Kinetics of Sn-117m(4+) DTPA in Patients With Multiple Metastatic Bone Pain[J].J Nucl Med,1995,(117):30.
  • 4OSTER Z H,SOM P,SRIVASTAVA S C,et al.The Development and in-vivo Behavior of Tin Containing Radiopharmaceutical.Ⅱ. Autoradiographic and Scintigraphic Studies in Normal Animals and in Animal Models of Bone Disease[J].Int J Nucl Med Biol,1985,12(3):175~184.

同被引文献39

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部